Earnings History Data for Chinook Therapeutics (KDNY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Chinook Therapeutics

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on developing precision medicines for kidney diseases. Chinook Therapeutics, Inc., formerly known as Aduro Biotech Inc., is based in BERKELEY, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-05-2023	AH		KDNY	Chinook Therapeutics	1,354	-0.85	-0.80	0.00	Chinook Therapeutics GAAP EPS of -$0.85, revenue of $1.8M [5/9/2023 6:05 PM]	23.12	1.60 (7.43%)	21.52	0.0 (0.00%)	12.49 - 27.44	508,233	840,000	11,485
Chinook Therapeutics GAAP EPS of -$0.85, revenue of $1.8M [5/9/2023 6:05 PM]
27-02-2023	AH		KDNY	Chinook Therapeutics	1,429	-0.90	-0.79	0.00	Chinook Therapeutics GAAP EPS of -$0.90 misses by $0.11, revenue of $0.51M beats by $0.41M [2/27/2023 4:05 PM]	21.79	0.22 (1.02%)	21.19	-0.38 (-1.76%)	11.81 - 27.44	1,399,612	630,000	35,074
Chinook Therapeutics GAAP EPS of -$0.90 misses by $0.11, revenue of $0.51M beats by $0.41M [2/27/2023 4:05 PM]
10-11-2022	AH		KDNY	Chinook Therapeutics	1,262	-0.83	-0.62	0.00	Chinook Therapeutics GAAP EPS of -$0.83 misses by $0.20, revenue of $2.5M beats by $2.38M [11/10/2022 5:14 PM]	21.61	-0.85 (-3.78%)	22.05	-0.41 (-1.83%)	11.16 - 23.86	1,135,472	650,000	133
Chinook Therapeutics GAAP EPS of -$0.83 misses by $0.20, revenue of $2.5M beats by $2.38M [11/10/2022 5:14 PM] Chinook Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results [Nov-10-22 04:00PM]
08-08-2022	AH		KDNY	Chinook Therapeutics	1,124	-0.61	-0.62	0.00	Chinook Therapeutics GAAP EPS of -$0.61 in-line, revenue of $0.42M in-line [8/8/2022 5:26 PM]	19.39	-1.10 (-5.37%)	20.49	0.0 (0.00%)	10.48 - 21.11	593,736	470,000	201
Chinook Therapeutics GAAP EPS of -$0.61 in-line, revenue of $0.42M in-line [8/8/2022 5:26 PM]
08-11-2021	PM		KDNY	Chinook Therapeutics	548.00	-0.68	-0.82	0.00	Chinook Therapeutics EPS beats by $0.15 [11/8/2021 8:54 AM]	14.16	-1.80 (-11.28%)	15.59	-0.37 (-2.32%)	10.48 - 21.68	845,504	570,000	19,613
Chinook Therapeutics EPS beats by $0.15 [11/8/2021 8:54 AM] Chinook Therapeutics proposes 6M share capital raise [11/8/2021 4:04 PM] Chinook Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results [Nov-08-21 08:00AM] Chinook Therapeutics Announces Proposed Public Offering of Common Stock [Nov-08-21 04:01PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	KDNY	Chinook Therapeutics, Inc.	548.00	-0.68	-0.76	0.00	Chinook Therapeutics EPS misses by $0.19, misses on revenue [8/12/2021 5:25 PM]	12.53	0.09 (0.72%)	12.44	0.0 (0.00%)	10.95 - 21.68	48,619	110,000	3,373
Chinook Therapeutics EPS misses by $0.19, misses on revenue [8/12/2021 5:25 PM] Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results [Aug-12-21 04:05PM]
12-05-2021	AH	4:05 PM ET (May 12)	KDNY	Chinook Therapeutics, Inc.	654.00	-0.83	-0.61	0.00	Chinook Therapeutics EPS misses by $0.24, beats on revenue [5/12/2021 4:46 PM]	14.99	-0.16 (-1.06%)	15.15	0.0 (0.00%)	10.50 - 21.68	134,560	250,000	1,206
Chinook Therapeutics EPS misses by $0.24, beats on revenue [5/12/2021 4:46 PM] Chinook Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results [May-12-21 04:05PM] Chinook Therapeutics to Present at the 2021 RBC Capital Markets Global Healthcare Conference [May-13-21 04:05PM]
07-04-2021	AH	5:05 PM ET (Apr 7)	KDNY	Chinook Therapeutics, Inc.	644.00	-1.19	-0.47	0.00	Chinook Therapeutics EPS misses by $0.75, misses on revenue [4/7/2021 4:17 PM]	14.41	-0.34 (-2.31%)	14.46	-0.29 (-1.97%)	10.50 - 21.68	132,081	170,000	2,005
Chinook Therapeutics files for $275M mixed shelf offering [4/7/2021 5:40 PM] Chinook Therapeutics EPS misses by $0.75, misses on revenue [4/7/2021 4:17 PM] Chinook Therapeutics starts dosing in mid-stage atrasentan study [4/7/2021 8:35 AM] Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results [Apr-07-21 04:05PM] Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases [Apr-07-21 08:15AM] Chinook Therapeutics to Present at Upcoming Investor Conferences [Apr-08-21 04:30PM]
05-11-2020	AH		KDNY	Chinook Therapeutics, Inc.	225.99	-0.90	-0.23	-1.30	Chinook Therapeutics reports Q3 results [11/5/2020 5:48 PM]	14.26	-0.63 (-4.23%)	14.79	0.0 (0.00%)	4.90 - 20.20	81,816	167,114	149